The role of hormonal and antiHER-2 therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER-2

Abstract

Targeting both the HR and HER-2 signaling pathways might be the effective tharapeutic strategy in the management of HR+/HER-2+ breast cancer. Clinical implication of dual treatment strategy are disscised.

Keywords

• Breast cancer
• HER-2
• metastasis